Quantum Labs
Bahasa Indonesia
Tesamorelin 5 mgPaket 10 vial2 stokHemat 17%
peptideintermediate2 stok

Tesamorelin 5 mg

Analog GHRH yang distabilkan

Tesamorelin GHRH analogue research peptide, Australian-shipped. Lab-verified ≥99% purity.

Strength
Dosis
5mg / vial
Bentuk
Serbuk liofilisasi
Paket
Paket 10 vial

Hanya untuk keperluan penelitian. Senyawa ini dijual secara ketat untuk penelitian in-vitro dan keperluan laboratorium, dan tidak dimaksudkan untuk konsumsi manusia atau penggunaan terapeutik. Dengan membeli, Anda menegaskan bahwa Anda adalah peneliti yang memenuhi syarat dan menyetujui penyangkalan lengkap kami.

Rp 3.090.906 IDR
Hemat 17%
Paket 10 vial
Sebelumnya Rp 3.724.020 IDR
Dijual sebagai paket 10 vial

Tersisa 2 paket

🧪Terverifikasi laboratorium
✓Diuji pihak ketiga
⚡Pengiriman cepat ke seluruh dunia
🔒Pembayaran kartu yang aman
Ikhtisar

Analog hormon pelepas hormon pertumbuhan yang distabilkan, dikaji untuk efek pada jaringan adiposa viseral dan aktivitas sumbu IGF-1 pada model riset.

Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.

Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

Mekanisme

Dikaji untuk pengikatan selektif pada reseptor GHRH dengan waktu paruh yang diperpanjang. Riset dikaitkan dengan penurunan penanda lemak viseral dan peningkatan IGF-1 pada populasi studi.

Laporan laboratorium

Diverifikasi HPLC terhadap spesifikasi kemurnian ≥99%. Diuji secara independen oleh laboratorium pihak ketiga terakreditasi.

FAQ peneliti

Tesamorelin — pertanyaan yang sering diajukan

What is Tesamorelin?

Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in growth-hormone research and pre-clinical models of metabolic regulation and body composition.

Is Tesamorelin legal in Australia?

Tesamorelin is not approved as a therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Tesamorelin for research use only.

What is the difference between Tesamorelin and CJC-1295?

Both are GHRH-analogue research peptides. CJC-1295 has a longer half-life and a stronger ability to extend the duration of GH pulses; Tesamorelin's modifications produce a shorter-acting but well-characterised GHRH-mimicking profile. They are studied as parallel research tools for different aspects of GHRH-pathway signalling.

What is the typical Tesamorelin research dosage?

Published clinical research (in the US, for the approved indication) has used 2 mg daily subcutaneous Tesamorelin. Research-protocol dosing varies by model. Human therapeutic dosing is not established in Australia.

Bacaan lanjutan

Panduan terkait Tesamorelin

Senyawa terkait

Peneliti juga menelusuri